OncoPep Revenue and Competitors
Estimated Revenue & Valuation
- OncoPep's estimated annual revenue is currently $1.2M per year.
- OncoPep's estimated revenue per employee is $77,500
- OncoPep's total funding is $28.4M.
Employee Data
- OncoPep has 16 Employees.
- OncoPep grew their employee count by 7% last year.
OncoPep's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | Senior Scientist Immunology and Oncology | Reveal Email/Phone |
OncoPep Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is OncoPep?
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
keywords:N/A
$28.4M
Total Funding
16
Number of Employees
$1.2M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 16 | 14% | $250.5M |
#2 | $1.4M | 16 | 0% | N/A |
#3 | $2.2M | 16 | -20% | $3M |
#4 | $2.2M | 16 | 0% | N/A |
#5 | $2.2M | 16 | -61% | N/A |